Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
6.00
-0.12 (-1.96%)
May 20, 2022 4:30 PM EDT - Market closed
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 |
|---|---|---|
| Market Capitalization | 188 | 534 |
| Enterprise Value | -48 | 243 |
| PE Ratio | - | -10.44 |
| PB Ratio | 0.68 | 1.79 |
| Debt / Equity Ratio | 0.11 | 0 |
| Current Ratio | 17.68 | 44.46 |
| Return on Equity (ROE) | - | -39.80% |
| Return on Assets (ROA) | - | -29.30% |
| Return on Capital (ROIC) | - | -1116.10% |
| Earnings Yield | -34.25% | -9.57% |
| FCF Yield | - | -10.38% |
| Buyback Yield / Dilution | - | -467.09% |
| Total Shareholder Return | - | -467.09% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).